case_images: PMC10496679_01
case_images: Liver biopsy results. Acute hepatitis with necroinflammatory infiltrate and acute pericentral necrosis and bleeding, sinusoidal dilation. Mild cholestasis. H&E staining. Scale bars indicate 500 microm (A) and 200 microm (B).
case_images: bmjno-2023-000481f01.jpg
case_images: PMC10496679_01_bmjno-2023-000481f01.jpg
case_images: F1
case_images: The liver biopsy findings were consistent, although not specific for iDILI (figure 1).
case_images: Time course of liver tests and association with oral cladribine and steroid treatment. ALT, alanine aminotransferase; AST, aspartate aminotransferase; GGT, gamma-glutamyl transferase.
case_images: bmjno-2023-000481f02.jpg
case_images: PMC10496679_01_bmjno-2023-000481f02.jpg
case_images: F2
case_images: The final second course of the second cycle of OC began on 17 October 2022 (total dosage 60 mg) in the absence of any change in the closely monitored LTs over the next 4 months (see figure 2 for time-course of LTs).